• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Exacerbation of immune thrombocytopenia following COVID-19 vaccination

Emily

Editor, Senior Moderator
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239625/
Kuter DJ. Exacerbation of immune thrombocytopenia following COVID-19 vaccination [published online ahead of print, 2021 Jun 1]. Br J Haematol. 2021;10.1111/bjh.17645. doi:10.1111/bjh.17645
Summary


There is concern that COVID‐19 vaccination may adversely affect immune thrombocytopenia (ITP) patients. Fifty‐two consecutive chronic ITP patients were prospectively followed after COVID‐19 vaccination. Fifteen percent had no worsening of clinical symptoms but no post‐vaccination platelet count; 73% had no new symptoms and no significant platelet count decline. However, 12% had a median platelet count drop of 96% within 2–5 days post vaccination with new bleeding symptoms; after rescue therapy with corticosteroids +/− intravenous immunoglobulin (IVIG), platelets recovered to >30 × 10[SUP]9[/SUP]/l a median three days later. ITP exacerbation occurred independently of remission status, concurrent ITP treatment, or vaccine type. Safety of a second vaccine dose needs careful assessment.


Keywords: immune thrombocytopenia, vaccination, COVID‐19, bleeding, rescue
 
Back
Top Bottom